Patents by Inventor Robert R. Granados
Robert R. Granados has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 7405038Abstract: Cell lines that are commonly used for protein expression are engineered to include genes that encode suppressors of apoptosis (SA). Insect cell lines expressing these SA genes are resistant to apoptosis or programmed cell death, and express certain recombinant proteins at increased levels. These cell lines also have increased resistance to many types of stress. Because some of the SA proteins inhibit apoptosis in a wide spectrum of organisms, these genes may be inserted into other plant or animal cell lines for a variety of purposes involving resistance to apoptosis or resistance to stress.Type: GrantFiled: March 3, 2000Date of Patent: July 29, 2008Assignee: Boyce Thompson Institute for Plant Research, Inc.Inventors: Gary Blissard, Robert R. Granados, Guangyun Lin
-
Patent number: 7179648Abstract: Improved insect cell lines, two of which are designated H5CL-B and H5CL-F (both of which are derived from the parental cell line BTI-TN-5B1-4, ATCC CRL 10859), possess the properties of increased production of baculovirus particles, increased expression of foreign proteins using a baculovirus expression system, and increased resistance to cell culture stress, relative to the parental cell line.Type: GrantFiled: November 14, 2003Date of Patent: February 20, 2007Assignee: Boyce Thompson Institute for Plant Research, Inc.Inventors: Robert R. Granados, Guoxun Li
-
Patent number: 6965059Abstract: Recent advances of the research on synergistic effect of a mixed baculovirus infection demonstrated the presence of viral molecules enhancing the early event of infection. The enhancins from the Trichoplusia ni was identified to have such a function, i.e., disrupting the structural integrity of peritrophic membrane of midgut of T. ni larva. The enhancin gene was ligated downstream of the CaMV 355 promoter of a binary vector pBI121. With a drug resistant gene, the gene was introduced to a piece of tobacco leaf, from Nicotiana tobacum cv. Havana SR1. We screened 11 regenerated plants out of 37 by feeding tobacco powder mixed in artificial diet, to 3rd instar Pseudaletia separata larvae. The larval stage was usually delayed from 1 to 3 days in comparison of that of control larvae. The larvae did not pupate normally. The larvae showed irregular morphology of half larva and half pupae, suggesting a hormonal disturbance caused by the transgenic tobacco.Type: GrantFiled: July 14, 1993Date of Patent: November 15, 2005Assignee: Boyce Thompson Institute for Plant Research, Inc.Inventors: Robert R. Granados, Yoshifumi Hashimoto
-
Patent number: 6765127Abstract: The invention represents the disclosure of an insect intestinal mucin (IIM) protein. The IIM protein was been identified and cloned using Trichoplusia ni larva. The cDNA and amino acid sequences have been determined and are disclosed. These sequences are useful for the production of transgenic cells, including plant cells, having insecticidal activity.Type: GrantFiled: April 19, 1999Date of Patent: July 20, 2004Assignee: Boyce Thompson Institute for Plant Research, Inc.Inventors: Robert R. Granados, Ping Wang
-
Patent number: 6403375Abstract: This disclosure presents the establishment of new cell lines from Trichoplusia ni eggs, in a commercial serum-free medium. These new cell lines were screened with wild-type Autographa californica multiple nuclear polyhedrosis virus (AcMNPV) and Trichoplusia ni single nuclear polyhedrosis virus (TnSNPV). In addition, selected cell lines from the initial screenings with the native baculoviruses, were further tested for their capacity to express recombinant proteins.Type: GrantFiled: August 24, 1994Date of Patent: June 11, 2002Assignee: Boyce Thompson Institute for Plant Research, Inc.Inventor: Robert R. Granados
-
Patent number: 6187558Abstract: The invention represents the disclosure of a novel insect intestinal mucin comprising two nearly identical isoforms, IIM14 and IIM22 respectively. These isoforms of the IIM protein have been identified and cloned using T. ni larva. The cDNA and amino acid sequences have been determined and are disclosed. Both IIM isoforms have an approximate molecular mass of 400 kDa. These sequences once disclosed are useful for the production of transgenic or recombinant vectors including viral, microorganism cell, plant, or animals, wherein the virus, microorganism, cell, plant, or animal is the product of an insertion of a gene expression vector including a DNA that encodes an IIM protein sequence. Thereafter the engineered host of the IIM DNA sequence is capable of expressing said IIM protein in a functional form. Also useful is a purified and isolated recombinant DNA sequence comprising a DNA sequence that codes for an IIM protein.Type: GrantFiled: June 24, 1998Date of Patent: February 13, 2001Assignee: Boyce Thompson Institute for Plant Research, Inc.Inventors: Robert R. Granados, Ping Wang
-
Patent number: 5717069Abstract: This disclosure relates to an isolated and cloned DNA from a granulovirus virus which comprises an amino acid sequence of the vital gene encoding a polypeptide isolated from occlusion bodies of certain baculoviruses and which polypeptide possesses the biological activity of enhancing baculovirus infectivity. Such proteins termed herein as "enhancins" are found within the viral occlusion body, have a disruptive effect on the insect peritrophic membrane (PM) proteins, and/or interact with the midgut epithelium in such a manner as to permit the increased adsorption, penetration and uptake of virus particles by midgut cells with a concomitant increase in host mortality. Disclosed herein is a recombinant DNA sequence which codes for the enhancin protein of the Helicoverpa armigera granulovirus virus. The DNA sequence is shown in SEQ. ID. NO.: 1 and the open reading frame is shown in SEQ. ID. NO.: 1: base pairs 271-2976. The amino acid sequence of the enhancin protein is shown in SEQ. ID. NO.: 2.Type: GrantFiled: August 23, 1996Date of Patent: February 10, 1998Assignee: Boyce Thompson Institute for Plant Research, Inc.Inventor: Robert R. Granados
-
Patent number: 5686305Abstract: This disclosure presents the establishment of a new cell line from Pseudaletia unipuncta embryos. This cell line demonstrated the ability to produce high numbers of baculoviruses in cell culture. These virus particles are found internally in the cells in occlusion bodies. In the study of Pseudaletia unipuncta two baculoviruses were found to infect this species: P. unipuncta nuclear polyhedrosis virus (PuNPV), and P. unipuncta granulosis virus (PuGV). In addition, the cell line was also selected and cultured for its ability to grow in suspension while maintaining high levels of OB production.Type: GrantFiled: February 26, 1997Date of Patent: November 11, 1997Assignee: Boyce Thompson Institute for Plant Research, Inc.Inventors: Ping Wang, Robert R. Granados
-
Patent number: 5475090Abstract: Cloning and sequencing certain baculovirus genes encoding polypeptides termed enhancins. The polypeptides are isolated from the occlusion body of certain baculoviruses such as Trichoplusia ni granulosis virus and Pseudaletia unipuncta granulosis virus, Hawaiian strain. The polypeptides have the ability of enhancing the infectivity of baculoviruses and are useful ingredients of pest control compositions.Type: GrantFiled: November 4, 1992Date of Patent: December 12, 1995Assignee: Boyce Thompson Institute for Plant ResearchInventors: Robert R. Granados, Yoshifumi Hashimoto
-
Patent number: 5348877Abstract: Normally anchorage-dependent insect cell lines are adapted to replicate under suspension conditions by addition of heparin to the culture medium and selection for resulting suspension-tolerant cells.Type: GrantFiled: March 12, 1993Date of Patent: September 20, 1994Assignee: Boyce Thompson Institute for Plant Research, Inc.Inventors: Kevin A. McKenna, Robert R. Granados
-
Patent number: 5300435Abstract: An insect cell line has been established and characterized, derived from embryonic tissue (BTI-TN-5B1-4, ATCC CRL 10859) of Trichoplusia ni (cabbage looper). The line is susceptible to various baculoviruses, including TnSNPV and AcMNPV, and may be used to replicate such viruses for use as insecticides or otherwise.Type: GrantFiled: December 1, 1992Date of Patent: April 5, 1994Assignee: Boyce Thompson Institute for Plant Research, Inc.Inventor: Robert R. Granados
-
Patent number: 5298418Abstract: Two new insect cell lines have been established and characterized; the cell lines were derived from midgut (BTI-TN-MG1, ATC CRL 10860), and embryonic tissue (BTI-TN-5B1-4, ATC CRL 10859) of Trichoplusia ni (cabbage looper). The lines are susceptible to various baculoviruses, including TnSNPV and AcMNPV, and may be used to replicate such viruses for use as insecticides or otherwise.Type: GrantFiled: February 21, 1992Date of Patent: March 29, 1994Assignee: Boyce Thompson Institute for Plant Research, Inc.Inventor: Robert R. Granados
-
Patent number: 5011685Abstract: Nuclear polyhedrosis viruses, for example, Autographa californica nuclear polyhedrosis virus (AcMNPV), useful in the control of lepidopterous larvae such as the larvae of the cabbage looper Trichoplusia ni, have been found to have enhanced infectivity when mixed with certain proteins obtained from the granulin fraction of Trichoplusia ni granulosis virus (TnGV) or Heliothis armigera granulosis virus (HaGV), and from the polyhedrin fraction of AcMNPV viruses. The proteins from the TnGV granulin fraction have molecular weights of about 101 and about 104 Kd. The enhanced infectivity is correlated to biochemical and structural changes in the T.ni peritrophic membrane.Type: GrantFiled: September 10, 1990Date of Patent: April 30, 1991Assignee: Boyce Thompson Institute for Plant Research, Inc.Inventor: Robert R. Granados
-
Patent number: 4973667Abstract: Nuclear polyhedrosis viruses, for example, Autographa californica nuclear polyhedrosis virus (AcMNPV), useful in the control of lepidopterous larvae such as the larvae of the cabbage looper Trichoplusia ni, have been found to have enhanced infectivity when mixed with certain proteins obtained from the granulin fraction of Trichoplusia ni granulosis virus (TnGV) or Heliothis armigera granulosis virus (HaGV), and from the polyhedrin fraction of AcMNPV viruses. The proteins from the TnGV granulin fraction have molecular weights of about 101 and about 104 kd. The enhanced infectivity is correlated to biochemical and structural changes in the T.ni peritrophic membrane.Type: GrantFiled: October 25, 1989Date of Patent: November 27, 1990Assignee: Boyce Thompson Institute for Plant Research, Inc.Inventor: Robert R. Granados